Amachiza okulwa nesithuthwane IBanga le-Pharma eliPhakathi Intengiso eshushu yePowder Tablets CAS 148553-50-8

                                               Ukusetyenziswa kwe-CAS 148553-50-8:

I-CAS 148553-50-8 yi-analog ye-neurotransmitter gamma-aminobutyric acid (GABA), ethengiswa phantsi kwegama lezorhwebo.NgoDisemba 2004, i-FDA yavuma i-CAS 148553-50-8 njengechiza lonyango lwe-neuralgia yesifo seswekile kunye ne-herpes zoster neuralgia.I-CAS 148553-50-8 lichiza lokuqala elavunywa yi-United States kunye neYurophu kunyango lwe-neuralgia. ngaphezulu kweentlobo ezimbini zeentlungu.NgoJuni 2005, i-CAS 148553-50-8 yamkelwa ukuba ifumane unyango lwe-adjuvant ye-partial-start-epilepsy yabantu abadala.Ngo-Matshi 2006, i-European Union yavuma i-CAS 148553-50-8 yonyango lwe-anxiety disorder disorder (GAD) kunye ne-social disorder disorder (SAD).
              
I-CAS 148553-50-8 isetyenziselwa ikakhulu unyango lwe-peripheral neuralgia kunye ne-adjuvant treatment of localized partial seizures.
I-CAS 148553-50-8 inokunciphisa ukukhululwa okuxhomekeke kwi-calcium kwezinye i-neurotransmitters ngokumodareyitha umsebenzi wesiteshi se-calcium.Nangona i-CAS 148553-50-8 i-derivative derivative of the inhibitory neurotransmitter γ-aminobutyric acid (GABA), ayibopheleli ngokuthe ngqo kwi-GABAA, i-GABAB, okanye i-benzodiazepine receptors kwaye ayinyusi i-GABAA kwi-Culture neurons Response, ayizange itshintshe. Ukuxinwa kwe-GABA kwingqondo yeegundane, kwaye ayizange ibe nefuthe elibukhali ekuthathweni okanye ekuthotyweni kwe-GABA.Nangona kunjalo, uphononongo lufumanise ukuba ukuvezwa ixesha elide kwee-neurons ezikhuliswe kwi-CAS 148553-50-8 kwandisa ukuxinana kwabathuthi be-GABA kunye nesantya sothutho olusebenzayo lwe-GABA.I-CAS 148553-50-8 ayivimbeli iziteshi ze-sodium, ayinayo umsebenzi kwi-opioid receptors, ayiguquli umsebenzi we-cyclooxygenase, ayinayo umsebenzi kwi-dopamine kunye ne-serotonin receptors, kwaye ayivimbeli ukuvuselelwa kwe-dopamine, i-serotonin, ukungena.